Pfizer

Pfizer Appoints New Chief Science Officer, Boosting Leadership in Oncology

1 month ago

Pfizer, one of the world’s leading biopharmaceutical companies, has announced a significant leadership change by appointing Dr. Angela Boshoff as its new Chief Science Officer (CSO). This move is notable, coming on the heels of her previous role leading the oncology division within the company, where she was instrumental in advancing Pfizer’s portfolio of cancer therapies.

Activist Investor Starboard Value Makes a Bold Move with a $1 Billion Stake in Pharmaceutical Giant Pfizer

3 months ago

In a significant financial maneuver, Starboard Value LP, a prominent activist investment firm, has acquired a substantial $1 billion stake in the global pharmaceutical behemoth Pfizer Inc. This strategic investment marks an assertive push by Starboard into the healthcare sector, aiming to influence the company's direction and potentially unlock shareholder value.

Pfizer’s Sickle Cell Drug Candidates Unaffected by Oxbryta Withdrawal

3 months ago

In what is a major development in the pharma space, Pfizer Inc. said that its set of upcoming sickle cell drug candidates remain unaffected by the recent withdrawal of Oxbryta, another medication pointed toward treating the same condition. An update comes amidst increased scrutiny on drug efficacy and regulatory compliance.